Bausch + Lomb launches PreserVision AREDS3 vitamins with B complex
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Bausch + Lomb Announces Published Review Examining the Role of B Vitamins in Reducing Risk and Progression of Age-Related Macular Degeneration
April 23, 2026 7:00 AM EDTDrawing on more than two decades of scientific evidence, a comprehensive review synthesizes more than 20 human studies highlighting the potential role of certain B vitamins in supporting eye health to help protect against age-related macular degeneration (AMD) PreserVision AREDS3 eye vitamins combine a unique B-vitamin complex with clinically proven AREDS2 nutrients, intended to expand eye-health support to a broad range of people* PreserVision AREDS3 eye vitamins enhanced with B vitamins are now available in the U.S. and are expected to be at most major retailers by June 2026 The strength of... More
